Optimization of sensitivity and specificity of a biomarker-based blood test (LVOCheck-Opti): A protocol for a multicenter prospective observational study of patients suspected of having a stroke.
Frontiers in Neurology · 2023-01-01 · Study protocol
Abstract
INTRODUCTION: Acute ischemic stroke (AIS) is a time-critical medical emergency. For patients with large-vessel occlusions (LVO), mechanical thrombectomy (MT) is the gold-standard treatment. Mobile Stroke Units (MSUs) provide on-site diagnostic capabilities via computed tomography (CT) and have been shown to improve functional outcomes in stroke patients, but are cost-efficient only in urban areas. Blood biomarkers have recently emerged as possible alternative to cerebral imaging for LVO diagnosis. Prehospital LVO diagnosis offers the potential to transport patients directly to centers that have MT treatment available. In this study, we assess the accuracy of combining two biomarkers, HFABP and NT-proBNP, with clinical indicators to detect LVO using ultra-early prehospital blood samples. The study was registered in the German Clinical Trials Register (DRKS-ID: DRKS00030399). METHODS AND ANALYSIS: We plan a multicenter prospective observational study with 800 patients with suspected stroke enrolled within 24 h of symptom onset. Study participants will be recruited at three sites (MSUs) in Berlin, Germany. Blood-samples will be taken pre-hospitally at the scene and tested for HFABP and NT-proBNP levels. Additional clinical data and information on final diagnosis will be collected and documented in an electronic case report form (eCRF). Sensitivity and specificity of the combination will be calculated through iterative permutation-response calculations. DISCUSSION: This study aims to evaluate the diagnostic capabilities of a combination of the biomarkers HFABP and NT-proBNP in LVO prediction. In contrast to most other biomarker studies to date, by employing MSUs as study centers, ultra-early levels of biomarkers can be analyzed. Point-of-care LVO detection in suspected stroke could lead to faster treatment in both urban and rural settings and thus improve functional outcomes on a broader scale. CLINICAL TRIAL REGISTRATION: Deutsches Register klinischer Studien https://drks.de/search/de/trial/DRKS00030399, DRKS00030399.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Mobile stroke unit · Point-of-care tests · Rural & remote · Urban
Related articles
- Quantifying the Impact of Acute Stroke System of Care Transfer Protocols on Patient Outcomes. (Med Decis Making, 2020)
- Effectiveness of mobile stroke units in reducing time to thrombolysis in acute ischemic stroke: a scoping review. (Int J Emerg Med, 2025)
- A scoping review of stroke services within the Philippines. (BMC Health Serv Res, 2024)
- Hybrid-Mobile Stroke Unit: Opening the Indication Spectrum for Stroke Mimics and Beyond. (Stroke Vasc Interv Neurol, 2023)
- Mobile stroke unit treatment times and transport frequency in a suburban setting. (Neurol Sci, 2025)
- Evaluation of the prehospital diagnostic accuracy of a novel point-of-care test for NT-proBNP, D-dimer and H-FABP and large-vessel occlusion risk assessment (LVOCheck-EVA): a protocol for a multicenter prospective observational study in patients suspected of having a stroke. (Front Neurol, 2025)